Related Experiment Video
Updated: May 22, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Molecular Approaches to Treating Chronic Obstructive Pulmonary Disease: Current Perspectives and Future Directions
Sheryl-Phuc Vu1, Kaleb Veit1, Ruxana T Sadikot1,2,3
1Division of Pulmonary, Critical Care & Sleep, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Chronic obstructive pulmonary disease (COPD) involves lung inflammation and oxidative stress. This review explores molecular strategies to develop novel therapies for COPD, addressing the limited treatment options for this growing global health challenge.
Area of Science:
- Pulmonary Medicine
- Molecular Biology
- Pathogenesis Research
Background:
- Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation and lung hyperinflation.
- It stems from chronic airway inflammation due to noxious particle/gas exposure, such as cigarette smoke.
- COPD involves persistent inflammation and oxidative stress, worsened by exacerbations, with rising global prevalence and mortality.
Purpose of the Study:
- To review molecular approaches for developing novel therapies for COPD.
- To address the lag in molecular therapeutic development despite increased understanding of COPD pathogenesis.
- To highlight potential strategies for future COPD treatment.
Main Methods:
- Literature review of molecular mechanisms in COPD.
- Analysis of current research on novel therapeutic targets.
- Synthesis of findings on molecular approaches for COPD treatment.
Main Results:
- Understanding of COPD pathogenesis has advanced significantly.
- Molecular approaches for novel therapy development have lagged behind.
- Several molecular pathways present potential therapeutic targets.
Conclusions:
- Molecular strategies offer promising avenues for novel COPD therapies.
- Further research into these molecular approaches is crucial for effective treatment.
- Targeting molecular pathways could mitigate COPD progression and improve patient outcomes.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Management Using Bronchodilators and Corticosteroids
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

